The 2022 Ryan White HIV/AIDS Program CLINICAL CONFERENCE

Course Chairs

Roger J. Bedimo, MD, MS
University of Texas Southwestern Medical Center
Laura W. Cheever, MD, ScM
The Health Resources and Services Administration
Michael S. Saag, MD
University of Alabama at Birmingham

Faculty

Laura Bachmann, MD, MPH
Centers for Disease Control and Prevention
Roger J. Bedimo, MD, MS
University of Texas Southwestern Medical Center
Constance A. Benson, MD
University of California San Diego
Jill Blumenthal, MD, MAS
University of California San Diego
R. Douglas Bruce
R. Douglas Bruce, MD, MA, MS
Boston University
Laura W. Cheever, MD, ScM
The Health Resources and Services Administration
Jason Farley, PhD, MPH, ANP-BC
Johns Hopkins University
Rajesh T. Gandhi, MD
Harvard Medical School
Nadine Kaslow
Nadine J. Kaslow, PhD
Emory University
H. Nina Kim, MD, MS
University of Washington
Richard Koup, MD
Vaccine Research Center, NIAID, NIH
Raphael J. Landovitz, MD
University of California Los Angeles
Judy Levison, MD, MPH
Baylor College of Medicine
Henry Masur, MD
The George Washington University
Aadia I. Rana, MD
University of Alabama at Birmingham
Michael S. Saag, MD
University of Alabama at Birmingham
David H. Spach, MD
University of Washington School of Medicine
Timothy J. Wilkin, MD, MPH
Weill Cornell Medicine

October 16-18, 2022

Address

Wyndham San Diego Bayside
1355 N Harbor Drive
San Diego
California
92101
United States

This activity is eligible for CME credits, ABIM MOC points, AAFP credits, nursing credits, and pharmacist credits.

Newly added: A meet-the-expert breakout session on Monkeypox 101 has been added to the program.

HEALTH AND SAFETY DURING THE CONFERENCE

For the health and safety of attendees, staff, and the local community, at this time, all attendees should be fully vaccinated and are required to wear a mask at all times while in the meeting room and other public spaces. If you feel sick prior to traveling, do not come. We plan to set up conference meeting rooms with adequate space for social distancing, sanitizing surfaces regularly, along with other precautions will be taken to ensure your safety throughout the conference. We will continue to monitor the Centers for Disease Control and Prevention guidelines as well as San Diego and California ordinances.

Overview

2022 RWHAP CLINICAL CONFERENCE Description

The 2022 Ryan White HIV/AIDS Program (RWHAP) CLINICAL CONFERENCE will be held in-person in San Diego, California, from Sunday, October 16, to Tuesday, October 18, as long as it is safe and practical to meet in-person. The RWHAP CLINICAL CONFERENCE will provide state-of-the-art updates on research, care, and treatment issues in the medical management of HIV infection for experienced HIV clinical decision makers.

The 2022 RWHAP CLINICAL CONFERENCE is planned with and supported by the HIV/AIDS Bureau, Health Resources and Services Administration of the US Department of Health and Human Services (HRSA) and is sponsored and organized by the International Antiviral Society-USA (IAS-USA). This conference is coordinated through the RWHAP AIDS Education and Training Centers (AETC) clinician training network. A mix of lectures, case-based interactive presentations, and small-group workshop breakout sessions will be held during the 3 days of the 2022 RWHAP CLINICAL CONFERENCE.

Who Should Attend

Attendance is limited to 400 HIV physicians, nurse practitioners, and physician assistants in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs (specifically for in part A, B, C, and D), who functions as medical director of their clinic. As we are not sure what the status of the COVID-19 pandemic will be in October, we are planning for distanced seating in the main meeting space. This will limit the number of attendees we can accommodate to ensure the health and safety of our attendees. The first 300 registrants will have access to seating in the main meeting room. The next 100 registrants will be in the overflow seating outside the main meeting room, but will still have access to breakout sessions and networking opportunities. At this point, given the limited attendance, in most cases there is a limit of 2 participants from each clinic, which can include 1 Registered Nurse and 1 Pharmacist.

The 2022 RWHAP CLINICAL CONFERENCE will offer limited number of registrations for RNs and PharmDs who are the primary clinical decision makers/medical directors in their RWHAP-funded clinics or programs.

There is no registration fee to attend.

Learning Objectives

The educational objectives for the 2022 RWHAP CLINICAL CONFERENCE are designed and developed based on the identified needs and knowledge gaps of the attendees.

On completion of the 2022 RWHAP CLINICAL CONFERENCE, participants will be able to:

  • Describe the new aspects to the Ryan White HIV/AIDS Program
  • Identify situations in which the choice of antiretroviral regimen should consider particular clinical circumstances, such as comorbid conditions, coinfections, pregnancy, and issues in older patients
  • Describe the most current data on currently available and investigational new antiretroviral drugs, formulations, and strategies
  • Initiate and monitor HIV prevention intervention strategies, including the use of long-acting injectable preexposure prophylaxis (PrEP), in individuals at risk for HIV infection
  • Describe the current epidemiology, clinical presentations, and management of the most common sexually transmitted infections (STIs) in adults with HIV infection and in special populations such as adolescents
  • Describe the current understanding of COVID-19 in people with HIV
  • Detect and address practitioner and staff burnout
  • Describe the current best practices of postnatal HIV care and prevention, including issues around breastfeeding
  • Describe the risk factors and screening recommendations for non-AIDS cancers in people with HIV
  • Diagnose and manage opportunistic infections in people with HIV
  • Implement key primary care practices
  • Describe the implications of mRNA vaccines for an HIV vaccine
  • Detect and manage opioid use disorder in people with HIV
  • Manage hepatitis B virus coinfection, including drug interactions and screening for hepatocellular carcinoma
  • Provide gender-affirming care to people with HIV
  • Address health disparities in disparate populations
  • Describe the current status of the Ending the HIV Epidemic initiative

IAS-USA Accreditation Statement

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Points

ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Academy of Family Physicians Credits

These activities are eligible for AAFP credit, see final AAFP activity announcement for specific details

Nursing Credits

These activities are eligible for ANCC credit, see final CNE activity announcement for specific details.

Pharmacy Credits

Accreditation Council for Pharmacy Education logo These activities are eligible for ACPE credit, see final CPE activity announcement for specific details.

Grant Support

This conference is funded by Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number U1OHA28686 (AIDS Education and Training Center National Coordinating Resource Center) awarded François-Xavier Bagnoud Center from the Rutgers University School of Nursing with a sub award to International Antiviral Society–USA (IAS–USA) to sponsor this CME activity.